Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Role of the lower limit of normal in COPD diagnosis.

A S Martín Hernández, M Solís García, L García Castellanos, M Hevia Menéndez, E Martínez Besteiro, J M Eiros Bachiller, C Marcos, R M Gómez-Punter, E Ávalos Pérez-Urria, G Iturricastillo Gutiérrez, J Ancochea Bermúdez
European Respiratory Journal 2022 60: 2549; DOI: 10.1183/13993003.congress-2022.2549
A S Martín Hernández
Hospital Universitario La Princesa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Solís García
Hospital Universitario La Princesa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
L García Castellanos
Hospital Universitario La Princesa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Hevia Menéndez
Hospital Universitario La Princesa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E Martínez Besteiro
Hospital Universitario La Princesa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J M Eiros Bachiller
Hospital Universitario La Princesa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C Marcos
Hospital Universitario La Princesa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R M Gómez-Punter
Hospital Universitario La Princesa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E Ávalos Pérez-Urria
Hospital Universitario La Princesa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G Iturricastillo Gutiérrez
Hospital Universitario La Princesa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Ancochea Bermúdez
Hospital Universitario La Princesa, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Introduction: According to GOLD, the diagnosis of chronic obstructive pulmonary disease (COPD) requires an FEV1/FVC ratio of less than 0.7. Another method that has been proposed is the use of the lower limit of normal (LLN), which represents the 5th percentile of the FEV1/FVC ratio of a healthy reference population.

Methods: The following variables were analyzed in a cohort of 59 patients diagnosed with COPD during 2021: sex, age, height, weight, BMI, cardiac comorbidities, grade of dyspnea (mMRC), number of exacerbations and admissions in the last year, FEV1, KCO and RV/TLC. They were classified into two groups: group A with an FEV1/FVC <0.7 and ≤LIN coinciding diagnosis by both methods and group B with an FEV1/FVC <0.7 but >LIN, with discordant diagnoses. The purpose of this study was to compare the characteristics of both groups.

Results: The mean age of the patients was 70.6 ± 7.80 years, 59.3% being male. They had a mean BMI of 28 and 19 (32.2%) were active smokers. 50 patients were classified in group A (84.7%) and 9 patients in group B (15.3%). There were no significant differences in terms of sex, anthropometric variables, exacerbations or grade of dyspnea. All patients in group B were older than 65 years, had a lower RV/TLC ratio and higher KCO than group A. Regarding to group A, the mean FEV1% was 52.8 ± 17.7, while in group B it was 77.0 ± 11.2, revealing statistically significant differences.

Conclusions: Patients in group B (not diagnosed with COPD by LIN) had better pulmonary function, nevertheless, they presented clinical manifestations and resource consumption similar to group A, so that the use of LIN as the only diagnostic criterion excludes excludes a large number of patients that require treatment and follow-up.

  • COPD - diagnosis
  • Chronic diseases
  • Spirometry

Footnotes

Cite this article as Eur Respir J 2022; 60: Suppl. 66, 2549.

This article was presented at the 2022 ERS International Congress, in session “-”.

This is an ERS International Congress abstract. No full-text version is available. Further material to accompany this abstract may be available at www.ers-education.org (ERS member access only).

  • Copyright ©the authors 2022
Previous
Back to top
Vol 60 Issue suppl 66 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Role of the lower limit of normal in COPD diagnosis.
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Role of the lower limit of normal in COPD diagnosis.
A S Martín Hernández, M Solís García, L García Castellanos, M Hevia Menéndez, E Martínez Besteiro, J M Eiros Bachiller, C Marcos, R M Gómez-Punter, E Ávalos Pérez-Urria, G Iturricastillo Gutiérrez, J Ancochea Bermúdez
European Respiratory Journal Sep 2022, 60 (suppl 66) 2549; DOI: 10.1183/13993003.congress-2022.2549

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Role of the lower limit of normal in COPD diagnosis.
A S Martín Hernández, M Solís García, L García Castellanos, M Hevia Menéndez, E Martínez Besteiro, J M Eiros Bachiller, C Marcos, R M Gómez-Punter, E Ávalos Pérez-Urria, G Iturricastillo Gutiérrez, J Ancochea Bermúdez
European Respiratory Journal Sep 2022, 60 (suppl 66) 2549; DOI: 10.1183/13993003.congress-2022.2549
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
  • Proadrenomedullin and copeptin are more sensitive and specific biomarkers for the prediction of mortality in stable COPD than fibrinogen: An analysis of the COSYCONET study
  • Evolution of the Use of Noninvasive Mechanical Ventilation in Chronic Obstructive Pulmonary disease
Show more 01.01 - Clinical problems - no related to asthma or COPD

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society